Glioblastoma — clinical trials in Denmark
10 open options
- TRIALPHASE4RECRUITING
Dabrafenib and/or Trametinib Rollover Study
dabrafenib · trametinib — 33 sites
- TRIALEARLY_PHASE1RECRUITING
Senicapoc and Perampanel for Newly Diagnosed Glioblastoma
senicapoc · Perampanel — 1 site
- TRIALPHASE3RECRUITING
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM
SonoCloud-9 (SC9) · Carboplatin · Lomustine — 55 sites
- TRIALNANOT_YET_RECRUITING
A Supportive Group Intervention for Caregivers to Patients Diagnosed With a Glioblastoma
Project SUGRI: A supportive group intervention for caregivers to patients with a glioblastoma — 1 site
- TRIALPHASE3RECRUITING
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Lomustine · Reirradiation — 45 sites
- TRIALNARECRUITING
Escalated Dose Proton Therapy Within the Multimodality Treatment of Glioblastoma Patients
Escalated proton therapy — 2 sites
- TRIALPHASE3RECRUITING
Lomustine in Addition to Standard of Care in Patients With MGMT Methylated Glioblastoma
Temozolomide · Lomustine — 20 sites
- TRIALPHASE1 / PHASE2RECRUITING
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Oral repotrectinib (TPX-0005) — 68 sites
- TRIALPHASE1 / PHASE2RECRUITING
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid Tumors
BAY 3713372 — 60 sites
- TRIALNANOT_YET_RECRUITING
PIRe 2.0: A Stepped-Care Model for Involving Relatives Across Sectors
Supportive Care — 1 site
Live from ClinicalTrials.gov, refreshed at most hourly · registry query ↗
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors.